(BLK) BlackRock - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US09290D1019
Stock: ETFs, Mutual Funds, Hedge Funds, Advisory Services, Portfolio Management
Total Rating 45
Risk 76
Buy Signal -0.87
| Risk 5d forecast | |
|---|---|
| Volatility | 38.9% |
| Relative Tail Risk | -6.73% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.08 |
| Alpha | -16.02 |
| Character TTM | |
|---|---|
| Beta | 1.049 |
| Beta Downside | 1.258 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.74% |
| CAGR/Max DD | 0.74 |
EPS (Earnings per Share)
Revenue
Description: BLK BlackRock February 25, 2026
BlackRock, Inc. (NYSE: BLK) is the world’s largest publicly-owned investment manager, offering a broad suite of services-including active and passive equity, fixed-income, multi-asset, real-estate, and alternative strategies-to institutional, intermediary, and individual clients worldwide. The firm designs and manages open- and closed-end funds, ETFs, hedge funds, and bespoke portfolios, employing both fundamental and quantitative, bottom-up and top-down analyses across global markets.
As of the latest quarter (Q4 2025), BlackRock reported $10.2 trillion in assets under management (AUM), a 4.3% year-over-year increase driven by strong inflows into its iShares ETFs and ESG-focused funds. Revenue rose to $19.8 billion, with net income of $5.4 billion, reflecting higher fee income from passive products and a favorable fixed-income environment as central banks maintain moderate rates. Key sector drivers include the continued shift toward low-cost passive investing, growing demand for sustainable assets, and robust capital-market activity in Europe-particularly in Poland and Germany’s real-estate markets where BlackRock is expanding its presence.
For deeper quantitative insights, consider exploring ValueRay’s analyst tools.
Headlines to watch out for
- AUM growth drives management fee income
- iShares ETF inflows boost revenue
- Technology services expand institutional offerings
- Interest rate hikes impact cash management
- Regulatory scrutiny increases compliance costs
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 5.55b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -1.28 > 1.0 |
| NWC/Revenue: 67.68% < 20% (prev 115.9%; Δ -48.21% < -1%) |
| CFO/TA 0.02 > 3% & CFO 3.97b > Net Income 5.55b |
| Net Debt (3.53b) to EBITDA (8.93b): 0.40 < 3 |
| Current Ratio: 70.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (165.4m) vs 12m ago 5.35% < -2% |
| Gross Margin: 55.52% > 18% (prev 0.49%; Δ 5503 % > 0.5%) |
| Asset Turnover: 15.69% > 50% (prev 14.72%; Δ 0.97% > 0%) |
| Interest Coverage Ratio: 10.70 > 6 (EBITDA TTM 8.93b / Interest Expense TTM 738.0m) |
Altman Z'' 2.06
| A: 0.10 (Total Current Assets 16.63b - Total Current Liabilities 237.0m) / Total Assets 170.00b |
| B: 0.22 (Retained Earnings 37.90b / Total Assets 170.00b) |
| C: 0.05 (EBIT TTM 7.90b / Avg Total Assets 154.31b) |
| D: 0.34 (Book Value of Equity 37.36b / Total Liabilities 108.46b) |
| Altman-Z'' Score: 2.06 = BBB |
Beneish M -2.94
| DSRI: 0.98 (Receivables 5.16b/4.45b, Revenue 24.22b/20.41b) |
| GMI: 0.89 (GM 55.52% / 49.42%) |
| AQI: 1.11 (AQ_t 0.88 / AQ_t-1 0.80) |
| SGI: 1.19 (Revenue 24.22b / 20.41b) |
| TATA: 0.01 (NI 5.55b - CFO 3.97b) / TA 170.00b) |
| Beneish M-Score: -2.94 (Cap -4..+1) = A |
What is the price of BLK shares?
As of March 09, 2026, the stock is trading at USD 955.45 with a total of 1,844,849 shares traded.
Over the past week, the price has changed by -10.07%, over one month by -11.03%, over three months by -9.53% and over the past year by +6.54%.
Over the past week, the price has changed by -10.07%, over one month by -11.03%, over three months by -9.53% and over the past year by +6.54%.
Is BLK a buy, sell or hold?
BlackRock has received a consensus analysts rating of 4.47.
Therefore, it is recommended to buy BLK.
- StrongBuy: 9
- Buy: 7
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BLK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1328.4 | 39% |
| Analysts Target Price | 1328.4 | 39% |
BLK Fundamental Data Overview March 07, 2026
P/E Trailing = 29.6732
P/E Forward = 19.0476
P/S = 6.6479
P/B = 2.8805
P/EG = 1.0703
Revenue TTM = 24.22b USD
EBIT TTM = 7.90b USD
EBITDA TTM = 8.93b USD
Long Term Debt = 12.77b USD (from longTermDebt, last quarter)
Short Term Debt = 237.0m USD (from shortTermDebt, last quarter)
Debt = 15.00b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.53b USD (from netDebt column, last quarter)
Enterprise Value = 164.51b USD (160.99b + Debt 15.00b - CCE 11.47b)
Interest Coverage Ratio = 10.70 (Ebit TTM 7.90b / Interest Expense TTM 738.0m)
EV/FCF = 45.81x (Enterprise Value 164.51b / FCF TTM 3.59b)
FCF Yield = 2.18% (FCF TTM 3.59b / Enterprise Value 164.51b)
FCF Margin = 14.83% (FCF TTM 3.59b / Revenue TTM 24.22b)
Net Margin = 22.93% (Net Income TTM 5.55b / Revenue TTM 24.22b)
Gross Margin = 55.52% ((Revenue TTM 24.22b - Cost of Revenue TTM 10.77b) / Revenue TTM)
Gross Margin QoQ = 63.13% (prev 59.90%)
Tobins Q-Ratio = 0.97 (Enterprise Value 164.51b / Total Assets 170.00b)
Interest Expense / Debt = 0.11% (Interest Expense 16.0m / Debt 15.00b)
Taxrate = 23.15% (372.0m / 1.61b)
NOPAT = 6.07b (EBIT 7.90b * (1 - 23.15%))
Current Ratio = 70.15 (Total Current Assets 16.63b / Total Current Liabilities 237.0m)
Debt / Equity = 0.27 (Debt 15.00b / totalStockholderEquity, last quarter 55.89b)
Debt / EBITDA = 0.40 (Net Debt 3.53b / EBITDA 8.93b)
Debt / FCF = 0.98 (Net Debt 3.53b / FCF TTM 3.59b)
Total Stockholder Equity = 52.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.60% (Net Income 5.55b / Total Assets 170.00b)
RoE = 10.65% (Net Income TTM 5.55b / Total Stockholder Equity 52.15b)
RoCE = 12.16% (EBIT 7.90b / Capital Employed (Equity 52.15b + L.T.Debt 12.77b))
RoIC = 9.36% (NOPAT 6.07b / Invested Capital 64.81b)
WACC = 8.95% (E(160.99b)/V(175.98b) * Re(9.78%) + D(15.00b)/V(175.98b) * Rd(0.11%) * (1-Tc(0.23)))
Discount Rate = 9.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.94%
[DCF] Terminal Value 73.90% ; FCFF base≈4.04b ; Y1≈3.85b ; Y5≈3.73b
[DCF] Fair Price = 336.1 (EV 55.81b - Net Debt 3.53b = Equity 52.28b / Shares 155.5m; r=8.95% [WACC]; 5y FCF grow -5.87% → 2.90% )
EPS Correlation: 75.32 | EPS CAGR: 9.02% | SUE: 2.40 | # QB: 1
Revenue Correlation: 85.63 | Revenue CAGR: 11.25% | SUE: 2.85 | # QB: 2
EPS next Quarter (2026-06-30): EPS=13.05 | Chg7d=+0.000 | Chg30d=-0.019 | Revisions Net=-1 | Analysts=11
EPS current Year (2026-12-31): EPS=54.38 | Chg7d=+0.000 | Chg30d=-0.057 | Revisions Net=-1 | Growth EPS=+13.1% | Growth Revenue=+15.7%
EPS next Year (2027-12-31): EPS=61.92 | Chg7d=+0.000 | Chg30d=-0.066 | Revisions Net=-1 | Growth EPS=+13.9% | Growth Revenue=+10.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.4% (Discount Rate 9.8% - Earnings Yield 3.4%)
[Growth] Growth Spread = +18.5% (Analyst 24.9% - Implied 6.4%)
P/E Forward = 19.0476
P/S = 6.6479
P/B = 2.8805
P/EG = 1.0703
Revenue TTM = 24.22b USD
EBIT TTM = 7.90b USD
EBITDA TTM = 8.93b USD
Long Term Debt = 12.77b USD (from longTermDebt, last quarter)
Short Term Debt = 237.0m USD (from shortTermDebt, last quarter)
Debt = 15.00b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.53b USD (from netDebt column, last quarter)
Enterprise Value = 164.51b USD (160.99b + Debt 15.00b - CCE 11.47b)
Interest Coverage Ratio = 10.70 (Ebit TTM 7.90b / Interest Expense TTM 738.0m)
EV/FCF = 45.81x (Enterprise Value 164.51b / FCF TTM 3.59b)
FCF Yield = 2.18% (FCF TTM 3.59b / Enterprise Value 164.51b)
FCF Margin = 14.83% (FCF TTM 3.59b / Revenue TTM 24.22b)
Net Margin = 22.93% (Net Income TTM 5.55b / Revenue TTM 24.22b)
Gross Margin = 55.52% ((Revenue TTM 24.22b - Cost of Revenue TTM 10.77b) / Revenue TTM)
Gross Margin QoQ = 63.13% (prev 59.90%)
Tobins Q-Ratio = 0.97 (Enterprise Value 164.51b / Total Assets 170.00b)
Interest Expense / Debt = 0.11% (Interest Expense 16.0m / Debt 15.00b)
Taxrate = 23.15% (372.0m / 1.61b)
NOPAT = 6.07b (EBIT 7.90b * (1 - 23.15%))
Current Ratio = 70.15 (Total Current Assets 16.63b / Total Current Liabilities 237.0m)
Debt / Equity = 0.27 (Debt 15.00b / totalStockholderEquity, last quarter 55.89b)
Debt / EBITDA = 0.40 (Net Debt 3.53b / EBITDA 8.93b)
Debt / FCF = 0.98 (Net Debt 3.53b / FCF TTM 3.59b)
Total Stockholder Equity = 52.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.60% (Net Income 5.55b / Total Assets 170.00b)
RoE = 10.65% (Net Income TTM 5.55b / Total Stockholder Equity 52.15b)
RoCE = 12.16% (EBIT 7.90b / Capital Employed (Equity 52.15b + L.T.Debt 12.77b))
RoIC = 9.36% (NOPAT 6.07b / Invested Capital 64.81b)
WACC = 8.95% (E(160.99b)/V(175.98b) * Re(9.78%) + D(15.00b)/V(175.98b) * Rd(0.11%) * (1-Tc(0.23)))
Discount Rate = 9.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.94%
[DCF] Terminal Value 73.90% ; FCFF base≈4.04b ; Y1≈3.85b ; Y5≈3.73b
[DCF] Fair Price = 336.1 (EV 55.81b - Net Debt 3.53b = Equity 52.28b / Shares 155.5m; r=8.95% [WACC]; 5y FCF grow -5.87% → 2.90% )
EPS Correlation: 75.32 | EPS CAGR: 9.02% | SUE: 2.40 | # QB: 1
Revenue Correlation: 85.63 | Revenue CAGR: 11.25% | SUE: 2.85 | # QB: 2
EPS next Quarter (2026-06-30): EPS=13.05 | Chg7d=+0.000 | Chg30d=-0.019 | Revisions Net=-1 | Analysts=11
EPS current Year (2026-12-31): EPS=54.38 | Chg7d=+0.000 | Chg30d=-0.057 | Revisions Net=-1 | Growth EPS=+13.1% | Growth Revenue=+15.7%
EPS next Year (2027-12-31): EPS=61.92 | Chg7d=+0.000 | Chg30d=-0.066 | Revisions Net=-1 | Growth EPS=+13.9% | Growth Revenue=+10.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.4% (Discount Rate 9.8% - Earnings Yield 3.4%)
[Growth] Growth Spread = +18.5% (Analyst 24.9% - Implied 6.4%)